Soligenix Starts Phase 3 Trial of HyBryte for Cuta...
Category : Clinical Trial Update 19 December 2024Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing pr...
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing pr...
Merck, known as MSD outside of the United States and Canada, announced the discontinuation of the cl...
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, kicked off the enro...
Bayer announced initiation of a phase I clinical trial with BAY3498264, an investigational oral sele...
Cipher Pharmaceuticals Inc, a specialty pharmaceutical company with a robust and diversified portfol...